DETERMINING THE MOLECULAR ENVELOPE OF THE COMPLEX OF A G-PROTEIN AND ITS RECEPTO
确定 G 蛋白复合物及其受体的分子包膜
基本信息
- 批准号:8362362
- 负责人:
- 金额:$ 0.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-03-01 至 2012-02-29
- 项目状态:已结题
- 来源:
- 关键词:Adrenergic ReceptorAgonistCollaborationsComplexConflict (Psychology)Electron MicroscopyFundingG-Protein-Coupled ReceptorsG-substrateGTP-Binding ProteinsGrantHeterotrimeric GTP-Binding ProteinsHormonesIndividualLigandsMeasurementMediatingMolecularMolecular ConformationMolecular Sieve ChromatographyNational Center for Research ResourcesNeurotransmittersNucleotidesPrincipal InvestigatorPropertyProteinsRadiationResearchResearch InfrastructureResourcesShapesSolutionsSourceStructureUnited States National Institutes of Healthcostreceptorreceptor bindingresponsesensory stimulusstoichiometrystructural biology
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
G-protein coupled receptors are 7-transmembrane helix proteins that mediate the majority of cellular responses to hormones, neurotransmitters, and sensory stimuli. In collaboration with Dr. Brian Kobilka, we have been studying crystal structures of the beta2-adrenergic receptor, a well-characterized G-protein coupled receptor. These were the first structures of a ligand-activated G protein coupled receptor. Thus far all structures of this and related receptors have been of the inactive state, and there are no structures of the active complex of receptor and G protein. A key question is how activating ligands stabilize the conformation of the receptor that can interact with its cognate heterotrimeric G protein and trigger nucleotide exchange. We have recently succeeded in producing a stable complex of the receptor bound to an activating ligand and a G protein. The complex, approximately 150kDa, is monodisperse as determined by size exclusion chromatography and electron microscopy. We propose solution x-ray scattering measurements to assess if we can obtain information about the overall shape of the complex, since we have the crystal structures of the two individual components. The determination of the stoichiometry between the receptor and G protein would be of significant importance as there are a number of conflicting results on oligomerization property of the receptor in the complex. We would also like to apply solution scattering to study effects of ligand and antagonists/agonists in the overall structure of the complex.
该子项目是利用资源的众多研究子项目之一
由 NIH/NCRR 资助的中心拨款提供。子项目的主要支持
并且子项目的主要研究者可能是由其他来源提供的,
包括其他 NIH 来源。 子项目可能列出的总成本
代表子项目使用的中心基础设施的估计数量,
NCRR 赠款不直接向子项目或子项目工作人员提供资金。
G 蛋白偶联受体是 7 次跨膜螺旋蛋白,介导大多数细胞对激素、神经递质和感觉刺激的反应。我们与 Brian Kobilka 博士合作,研究了 β2 肾上腺素受体(一种已充分表征的 G 蛋白偶联受体)的晶体结构。这些是配体激活的 G 蛋白偶联受体的第一个结构。迄今为止,该受体及相关受体的所有结构均处于非活性状态,并且没有受体与G蛋白的活性复合物的结构。一个关键问题是激活配体如何稳定受体的构象,从而与其同源异三聚体 G 蛋白相互作用并触发核苷酸交换。我们最近成功地生产了与激活配体和 G 蛋白结合的受体的稳定复合物。通过尺寸排阻色谱法和电子显微镜测定,该复合物大约为 150kDa,是单分散的。我们提出了溶液 X 射线散射测量来评估我们是否可以获得有关复合物整体形状的信息,因为我们拥有两个单独组件的晶体结构。受体和 G 蛋白之间化学计量的确定非常重要,因为复合物中受体的寡聚特性存在许多相互矛盾的结果。我们还想应用溶液散射来研究配体和拮抗剂/激动剂在复合物整体结构中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William I Weis其他文献
William I Weis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William I Weis', 18)}}的其他基金
Nanobody- and mini-G protein-enabled molecular pharmacology of HCAR1
HCAR1 的纳米抗体和迷你 G 蛋白分子药理学
- 批准号:
10666999 - 财政年份:2023
- 资助金额:
$ 0.74万 - 项目类别:
Molecular mechanisms of Wnt and mechanical signaling through β-catenin
Wnt 的分子机制和通过 β-catenin 的机械信号传导
- 批准号:
10404076 - 财政年份:2019
- 资助金额:
$ 0.74万 - 项目类别:
Molecular mechanisms of Wnt and mechanical signaling through β-catenin
Wnt 的分子机制和通过 β-catenin 的机械信号传导
- 批准号:
10299581 - 财政年份:2019
- 资助金额:
$ 0.74万 - 项目类别:
Molecular mechanisms of Wnt and mechanical signaling through β-catenin
Wnt 的分子机制和通过 β-catenin 的机械信号传导
- 批准号:
10382116 - 财政年份:2019
- 资助金额:
$ 0.74万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 0.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 0.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 0.74万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 0.74万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 0.74万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 0.74万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 0.74万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 0.74万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 0.74万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 0.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




